Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Glauconix Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Glauconix Biosciences

Glauconix Biosciences

Seed

Glauconix Biosciences, a NY-based software company, innovates in ophthalmic drug development.

HQ
Albany, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Glauconix Biosciences, founded in Albany, New York, operates from the SUNY Polytechnic Institute campus. The company specializes in ophthalmic drug development, leveraging a proprietary platform technology to reduce costs and accelerate the process. Their core mission is to advance eye care by providing innovative solutions for drug testing and development. Glauconix offers various models, including glaucoma and retinal vascular dysfunction models, to support pharmaceutical research and development.

Notable figures associated with Glauconix include experts from the fields of ophthalmology and pharmaceutical sciences. The company has secured investments from prominent biotech investors and has received recognition for its contributions to reducing the time and cost of drug development. Glauconix's impact is significant in the pharmaceutical industry, providing advanced tools that enhance the efficiency and effectiveness of ophthalmic drug research.

Glauconix Biosciences - Similar Companies

Glaukos logo

Glaukos

glaukos.com

Spyglass Pharma logo

Spyglass Pharma

spyglasspharma.com

SpyGlass Ophthalmics logo

SpyGlass Ophthalmics

Adtech Pharma logo

Adtech Pharma

adtechpharma.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Visiox logo

Visiox

visioxpharma.com

Glycologix logo

Glycologix

glycologix.com

EyeCyte logo

EyeCyte

eyecyte.com

Orange Grove Bio logo

Orange Grove Bio

orangegrovebio.com

Greenstone Biosciences logo

Greenstone Biosciences

Xontogeny logo

Xontogeny

xontogeny.com

Ocular Science logo

Ocular Science

ocularscience.com

Endogenx logo

Endogenx

GeneCentrix logo

GeneCentrix

genecentrix.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Glauconix Biosciences - Quick Facts

Who are Glauconix Biosciences' competitors?

Companies similar to Glauconix Biosciences include Glaukos, Spyglass Pharma, SpyGlass Ophthalmics and Adtech Pharma.

When was Glauconix Biosciences founded?

Glauconix Biosciences was founded in 2014.

Where is Glauconix Biosciences' headquarters located?

Glauconix Biosciences' headquarters is located in Albany, NY, US.

When was Glauconix Biosciences' last funding round?

Glauconix Biosciences' most recent funding round was for $100k (USD) in May 2018.

How much has Glauconix Biosciences raised to-date?

As of May 31, 2018, Glauconix Biosciences has raised a total of $2.2M (USD).

How many employees does Glauconix Biosciences have?

Glauconix Biosciences has 8 employees as of Feb 4, 2024.

Glauconix Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Consulting
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research